X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (614) 614
Publication (49) 49
Patent (19) 19
Book Review (10) 10
Book Chapter (8) 8
Conference Proceeding (3) 3
Magazine Article (3) 3
Book / eBook (1) 1
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (348) 348
male (224) 224
index medicus (223) 223
infectious diseases (209) 209
adult (201) 201
female (194) 194
hiv (180) 180
hiv infections - drug therapy (166) 166
middle aged (164) 164
immunology (117) 117
hiv infections - complications (110) 110
virology (103) 103
viral load (89) 89
antiretroviral therapy (81) 81
hepatitis c (80) 80
human immunodeficiency virus--hiv (79) 79
treatment outcome (78) 78
hiv infections - virology (75) 75
human-immunodeficiency-virus (65) 65
aids (63) 63
cd4 lymphocyte count (62) 62
aged (61) 61
anti-hiv agents - therapeutic use (61) 61
infection (61) 61
risk factors (59) 59
antiviral agents - therapeutic use (58) 58
hiv infections - immunology (58) 58
drug therapy (57) 57
drug therapy, combination (57) 57
hiv infection (57) 57
hepatitis (54) 54
young adult (54) 54
antiviral agents (52) 52
pharmacology & pharmacy (52) 52
health aspects (51) 51
genotype (50) 50
microbiology (50) 50
mortality (48) 48
hepatitis c - complications (46) 46
hepatitis c virus (46) 46
hcv (45) 45
hepatitis c - drug therapy (44) 44
infected patients (44) 44
aids/hiv (43) 43
gastroenterology & hepatology (43) 43
research (43) 43
infections (42) 42
cohort studies (41) 41
therapy (41) 41
adolescent (40) 40
antiretroviral drugs (39) 39
antiretroviral therapy, highly active (39) 39
highly active antiretroviral therapy (38) 38
rna, viral - blood (38) 38
disease progression (37) 37
active antiretroviral therapy (36) 36
analysis (36) 36
hiv patients (36) 36
care and treatment (35) 35
ribavirin (35) 35
disease (34) 34
europe (34) 34
hepatitis c, chronic - drug therapy (34) 34
coinfection (33) 33
comorbidity (33) 33
hepacivirus - genetics (33) 33
hiv infections - epidemiology (33) 33
hiv-1 (33) 33
prevalence (31) 31
human immunodeficiency virus (30) 30
prospective studies (30) 30
epidemiology (29) 29
hepatitis c, chronic - complications (29) 29
ribavirin - therapeutic use (29) 29
virus diseases (29) 29
liver diseases (28) 28
tenofovir (28) 28
acquired immune deficiency syndrome--aids (27) 27
cirrhosis (27) 27
interferon (27) 27
liver (27) 27
medicine (27) 27
dosage and administration (26) 26
progression (26) 26
anti-hiv agents - adverse effects (25) 25
efficacy (25) 25
hiv-1 - drug effects (25) 25
hiv-infected patients (25) 25
interferon-alpha - therapeutic use (25) 25
medicine, general & internal (25) 25
time factors (25) 25
viruses (25) 25
anti-retroviral agents - therapeutic use (24) 24
hiv-1 - genetics (24) 24
research article (24) 24
fibrosis (23) 23
risk (23) 23
anti-hiv agents - administration & dosage (22) 22
cohort (22) 22
coinfection - drug therapy (22) 22
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Rodger, Alison J and Cambiano, Valentina and Bruun, Tina and Vernazza, Pietro and Collins, Simon and Degen, Olaf and Corbelli, Giulio Maria and Estrada, Vicente and Estrada, Vicente P and Geretti, Anna Maria and Beloukas, Apostolos and Raben, Dorthe and Coll, Pep and Antinori, Andrea and Nwokolo, Nneka and Rieger, Armin and Prins, Jan M and Prins, Jan and Blaxhult, Anders and Weber, Rainer and Van Eeden, Arne and Brockmeyer, Norbert and Brockmeyer, Norbert H and Clarke, Amanda and del Romero Guerrero, Jorge and Raffi, Francois and Bogner, Johannes R and Bogner, Johannes and Wandeler, Gilles and Gerstoft, Jan and Gutiérrez, Felix and Brinkman, Kees and Kitchen, Maria and Ostergaard, Lars and Leon, Agathe and Ristola, Matti and Jessen, Heiko and Jessen, Arne and Stellbrink, Hans-Jürgen and Phillips, Andrew N and Lundgren, Jens and Cobarsi, Patricia and Nieto, Aroa and Meulbroek, Michael and Carrillo, Antonia and Saz, Jorge and Guerrero, Jorge D.R and García, Mar Vera and Masiá, Mar and Robledano, Catalina and Leal, Lorna and Redondo, Eva G and Marquez, Rocio and Sandoval, Raquel and Viciana, Pompeyo and Espinosa, Nuria and Lopez-Cortes, Luis and Podzamczer, Daniel and Tiraboschi, Juan and Morenilla, Sandra and Antela, Antonio and Losada, Elena and Sewell, Janey and Kirk, Sarah and Knott, Alyson and Fernandez, Thomas and Gompels, Mark and Jennings, Louise and Ward, Lana and Fox, Julie and Lwanga, Julianne and Lee, Ming and Gilson, Richard and Leen, Clifford and Morris, Sheila and Clutterbuck, Dan and Brady, Michael and Asboe, David and Fedele, Serge and Fidler, Sarah and Potthoff, Anja and Skaletz-Rorowski, Adriane and Seybold, Ulrich and Roider, Julia and Ruzicic, Slobodan and Kümmerle, Tim and Lehmann, Clara and Bartel, Sindy and Hüfner, Anja and Rockstroh, Jürgen and Mohrmann, Karina and Boesecke, Christoph and Krznaric, Ivanka and Ingiliz, Patrick and Grube, Christina and Braun, Dominique and Günthard, Huldrych and Furrer, Hansjakob and Rauch, Andri and Schmid, Patrick and ... and PARTNER Study Grp and PARTNER Study Group
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10189, pp. 2428 - 2438
Journal Article
MMW Fortschritte der Medizin, ISSN 1438-3276, 04/2004, Volume 146, pp. 18 - 19
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2011, Volume 6, Issue 9, p. e23946
Background/Aim of the Study: The study aimed to determine the cost impacts of antiretroviral drugs by analysing a long-term follow-up of direct costs for... 
INDIVIDUALS | THERAPY | PRICE | DRUGS | EMTRICITABINE | BIOLOGY | INFECTION | STRATEGIES | REDUCE | LIFE | Anti-HIV Agents - pharmacology | Anti-HIV Agents - economics | Follow-Up Studies | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Drugs, Generic - economics | Reverse Transcriptase Inhibitors - pharmacology | Male | Drugs, Generic - therapeutic use | Protease Inhibitors - pharmacology | Drug Prescriptions - economics | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Protease Inhibitors - therapeutic use | Drugs, Generic - pharmacology | Reverse Transcriptase Inhibitors - economics | Protease Inhibitors - economics | Drug Therapy, Combination - economics | Drug Prescriptions - statistics & numerical data | HIV Infections - drug therapy | Cost Savings - statistics & numerical data | Germany | Cohort Studies | Highly active antiretroviral therapy | Medical research | Generic drugs | Protease inhibitors | Proteases | Analysis | Economic aspects | Medicine, Experimental | HIV (Viruses) | Health care | Drugs | Antiretroviral drugs | Therapy | Costs | Ritonavir | Medical treatment | Resource allocation | Medical services | Cost reduction | Data processing | Disease control | Antiretroviral therapy | Prescription drugs | Inhibitors | Taxes | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Taxation | Cost analysis | Cost engineering | Pharmaceuticals | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 3, p. e17781
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2018, Volume 66, Issue 9, p. 1366
In May 2016, the World Health Assembly endorsed the Global Health Sector Strategy (GHSS) on viral hepatitis 2016–2021. The GHSS calls for the elimination of... 
Hepatitis | Health risks | Viruses | Hepatitis C virus | Hepatitis C | Public health
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 4/2008, Volume 61, Issue 4, pp. 914 - 918
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9835, pp. 2429 - 2438
Summary Background The HIV integrase strand transfer inhibitor elvitegravir (EVG) has been co-formulated with the CYP3A4 inhibitor cobicistat (COBI),... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | TREATMENT-NAIVE | PHARMACOKINETICS | RALTEGRAVIR | SAFETY | EFAVIRENZ | ADULTS | SINGLE-TABLET REGIMEN | PATIENTS 96-WEEK EFFICACY | COMBINATION | ADHERENCE | HIV-1 | Humans | Middle Aged | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Anti-HIV Agents - administration & dosage | Tenofovir | Atazanavir Sulfate | Adult | Female | Emtricitabine | Adenine - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Ritonavir - administration & dosage | Deoxycytidine - administration & dosage | Adenine - administration & dosage | Organophosphonates - administration & dosage | Quinolones - administration & dosage | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Antiviral agents | Patient outcomes | Dosage and administration | Research | Comparative analysis | Drug therapy | HIV infection | Anti-HIV agents | Antiretroviral drugs | Bone density | Pharmaceutical industry | Human immunodeficiency virus--HIV | Pneumonia | Laboratories | Ritonavir | Liver | Infections | Drug resistance | Hepatitis | Randomization | All terrain vehicles | Creatinine | Integrase | Data processing | Proteinase inhibitors | Behavior disorders | Ribonucleic acid--RNA | Patients | Cholesterol | Glomerular filtration rate | Inhibitors | Protease inhibitors | Interactive systems
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2018, Volume 13, Issue 1, p. e0191118
Journal Article
HIV medicine, ISSN 1464-2662, 2016, Volume 17, Issue 2, pp. 83 - 88
BackgroundThe European AIDS Clinical Society (EACS) guidelines are intended for all clinicians involved in the care of HIV-positive persons, and are available... 
opportunistic infections | ART | HIV | comorbidities | HCV | EACS | antiretroviral treatment | HBV | Guidelines | Opportunistic infections | Comorbidities | Antiretroviral treatment | INFECTIOUS DISEASES | Immune Reconstitution Inflammatory Syndrome - prevention & control | Guidelines as Topic | Immune Reconstitution Inflammatory Syndrome - diagnosis | HIV Infections - epidemiology | Humans | Male | Viral Load | Drug Interactions | Societies, Medical | HIV Infections - diagnosis | Pregnancy Complications, Infectious - prevention & control | Post-Exposure Prophylaxis | Adult | Female | Pregnancy Complications, Infectious - diagnosis | Standard of Care | Comorbidity | AIDS-Related Opportunistic Infections - drug therapy | Europe - epidemiology | AIDS-Related Opportunistic Infections - diagnosis | CD4 Lymphocyte Count | Pre-Exposure Prophylaxis | Antiretroviral Therapy, Highly Active | Pregnancy | AIDS-Related Opportunistic Infections - prevention & control | Pregnancy Complications, Infectious - drug therapy | Immune Reconstitution Inflammatory Syndrome - drug therapy | HIV Infections - drug therapy | Antiviral agents | Liver diseases | Practice guidelines (Medicine) | HIV patients | Biological response modifiers | HIV (Viruses) | Highly active antiretroviral therapy | AIDS (Disease) | Drug therapy | Hepatitis C virus | Hepatitis C | Health aspects
Journal Article